On the public citation graph
Endogenous innovations in the pharmaceutical industry
0 signed · 75 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/0471667196.ess2527openalex-snapshot
Statistical Abstract of the U nited S tates
inferredcites →https://doi.org/10.1007/978-3-662-11287-8_11openalex-snapshot
The determinants of pharmaceutical research and development expenditures
inferredcites →https://doi.org/10.1007/bf00056139openalex-snapshot
The value of changes in life expectancy
inferredcites →https://doi.org/10.1007/s001910050012openalex-snapshot
The determinants of pharmaceutical research and development expenditures
inferredcites →https://doi.org/10.1007/s10754-005-6601-7openalex-snapshot
The Impact of New Drug Launches on Longevity: Evidence from Longitudinal, Disease-Level Data from 52 Countries, 1982?2001
inferredcites →https://doi.org/10.1016/0167-6296(91)90001-4openalex-snapshot
Cost of innovation in the pharmaceutical industry
inferredcites →https://doi.org/10.1016/0167-6296(94)90010-8openalex-snapshot
Returns to R&D on new drug introductions in the 1980s
inferredcites →https://doi.org/10.1016/0304-4076(81)90081-6openalex-snapshot
On the concept of non-significant functions and its implications for regression analysis
inferredcites →https://doi.org/10.1016/0737-6782(87)90021-xopenalex-snapshot
Longer patents for lower imitation barriers: The 1984 Drug Act
inferredcites →https://doi.org/10.1017/cbo9780511493232.002openalex-snapshot
Pharmaceutical innovation as a process of creative destruction
inferredcites →https://doi.org/10.1038/clpt.1994.78openalex-snapshot
New drug development in the United States from 1963 to 1992
inferredcites →https://doi.org/10.1080/00324728.1978.10410715openalex-snapshot
Urban French Mortality in the Nineteenth Century
inferredcites →https://doi.org/10.1086/259401openalex-snapshot
The Determinants of Industrial Research and Development: A Study of the Chemical, Drug, and Petroleum Industries
inferredcites →https://doi.org/10.1086/259862openalex-snapshot
Research and Development Costs and Returns: The U.S. Pharmaceutical Industry
inferredcites →https://doi.org/10.1086/259880openalex-snapshot
On the Concept of Health Capital and the Demand for Health
inferredcites →https://doi.org/10.1086/260107openalex-snapshot
An Evaluation of Consumer Protection Legislation: The 1962 Drug Amendments
inferredcites →https://doi.org/10.1086/261016openalex-snapshot
The Adjustment of Consumption to Changing Expectations About Future Income
inferredcites →https://doi.org/10.1086/261705openalex-snapshot
A Model of the Demand for Longevity and the Value of Life Extension
inferredcites →https://doi.org/10.1086/466914openalex-snapshot
Estimating the Effects of Regulation on Innovation: An International Comparative Analysis of the Pharmaceutical Industry
inferredcites →https://doi.org/10.1086/467257openalex-snapshot
Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act
inferredcites →https://doi.org/10.1093/fampra/16.4.407openalex-snapshot
Diffusion of new drugs in Danish general practice
inferredcites →https://doi.org/10.1162/003355398555801openalex-snapshot
Are Medical Prices Declining? Evidence from Heart Attack Treatments
inferredcites →https://doi.org/10.1257/00028280260344768openalex-snapshot
Using Electoral Cycles in Police Hiring to Estimate the Effect of Police on Crime: Comment
inferredcites →https://doi.org/10.1257/aer.89.5.1358openalex-snapshot
Longevity Complementarities Under Competing Risks
inferredcites →https://doi.org/10.1257/jep.6.3.3openalex-snapshot
Medical Care Costs: How Much Welfare Loss?
inferredcites →https://doi.org/10.1377/hlthaff.20.5.136openalex-snapshot
Perspectives On The Pharmaceutical Industry
inferredcites →https://doi.org/10.1377/hlthaff.20.5.216openalex-snapshot
The Link Between Gross Profitability And Pharmaceutical R&D Spending
inferredcites →https://doi.org/10.2165/00019053-200220003-00002openalex-snapshot
Returns on Research and Development for 1990s New Drug Introductions
inferredcites →https://doi.org/10.22004/ag.econ.268957openalex-snapshot
MONOPOLISTIC COMPETITION AND OPTIMUM PRODUCT DIVERSITY
inferredcites →https://doi.org/10.2307/134415openalex-snapshot
The Determinants of R & D Expenditures
inferredcites →https://doi.org/10.2307/1911894openalex-snapshot
The Distributed Lag Between Capital Appropriations and Expenditures
inferredcites →https://doi.org/10.2307/1923966openalex-snapshot
Technical Change and Firm Size: The Pharmaceutical Industry
inferredcites →https://doi.org/10.2307/1927919openalex-snapshot
Intrafirm Rates of Diffusion of an Innovation
inferredcites →https://doi.org/10.2307/2098683openalex-snapshot
How Rapidly Does New Industrial Technology Leak Out?
inferredcites →https://doi.org/10.2307/2297319openalex-snapshot
Product Selection, Fixed Costs, and Monopolistic Competition
inferredcites →https://doi.org/10.2307/2696376openalex-snapshot
Pricing and R&D When Consumption Affects Longevity
inferredcites →https://doi.org/10.3386/w12120openalex-snapshot
The Impact of New Laboratory Procedures and Other Medical Innovations on the Health of Americans, 1990-2003: Evidence from Longitudinal, Disease-Level Data
inferredcites →https://doi.org/10.3386/w1402openalex-snapshot
Nutrition and the Decline in Mortality Since 1700: Some Preliminary Findings
inferredcites →https://doi.org/10.3386/w6601openalex-snapshot
The Allocation of Publicly-Funded Biomedical Research
inferredcites →https://doi.org/10.3386/w8147openalex-snapshot
The Benefits and Costs of Newer Drugs: Evidence from the 1996 Medical Expenditure Panel Survey
inferredcites →https://doi.org/10.3386/w8677openalex-snapshot
The Effect of New Drugs on Mortality from Rare Diseases and HIV
inferredcites →https://doi.org/10.3386/w8755openalex-snapshot
Sources of U.S. Longevity Increase, 1960-1997
inferredcites →https://doi.org/10.7208/chicago/9780226551791.003.0003openalex-snapshot
The Economic Value of Medical Research
inferredcites →https://doi.org/10.7312/gros17812-004openalex-snapshot
1. On the Concept of Health Capital and the Demand for Health
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.1983256openalex-extracted
The Impact of Public Basic Research on Industrial Innovation: Evidence from the Pharmaceutical Industry
inferred← citeshttps://doi.org/10.2139/ssrn.2524960openalex-extracted
Of Marshallian Scissors & Blades: Demand Shocks, Import Exposure, and Innovation in Indian Influenza-Vaccine Markets
inferred← citeshttps://doi.org/10.2139/ssrn.3325987openalex-extracted
Lessons for Tax Reform from an Equilibrium Model of Innovation
inferred← citeshttps://doi.org/10.1007/s00191-017-0524-6openalex-snapshot
Determinants of pharmaceutical innovation: the role of technological opportunities revisited
inferred← citeshttps://doi.org/10.1007/s10368-008-0116-xopenalex-snapshot
Firm boundary decisions: the market for health-related R&D services with an empirical case study for Germany
inferred← citeshttps://doi.org/10.1016/j.euroecorev.2019.103350openalex-snapshot
Innovation-led growth in a time of debt
inferred← citeshttps://doi.org/10.1016/j.hlpt.2013.09.005openalex-snapshot
Pharmaceutical innovation and longevity growth in 30 developing and high-income countries, 2000–2009
inferred← citeshttps://doi.org/10.1016/j.respol.2011.06.004openalex-snapshot
The impact of public basic research on industrial innovation: Evidence from the pharmaceutical industry
inferred← citeshttps://doi.org/10.1016/j.respol.2018.03.003openalex-snapshot
Market size and innovation: The intermediary role of technology licensing
inferred← citeshttps://doi.org/10.1016/s0169-7218(10)01004-xopenalex-snapshot
Fifty Years of Empirical Studies of Innovative Activity and Performance
inferred← citeshttps://doi.org/10.1080/09537325.2011.621300openalex-snapshot
Knowledge organisation in R&D alliances: its impact on product innovation
inferred← citeshttps://doi.org/10.1080/13662716.2016.1150157openalex-snapshot
Product innovation success based on cancer research in the pharmaceutical industry: co-publication networks and the effects of partners
inferred← citeshttps://doi.org/10.1093/ej/uead028openalex-snapshot
Labour Taxes, Market Size and Productivity Growth
inferred← citeshttps://doi.org/10.1093/icc/dtab064openalex-snapshot
The long-term economic effects of pandemics: toward an evolutionary approach
inferred← citeshttps://doi.org/10.1111/1756-2171.12113openalex-snapshot
Market size and pharmaceutical innovation
inferred← citeshttps://doi.org/10.1111/1756-2171.12422openalex-snapshot
Does consumer demand pull scientifically novel drug innovation?
inferred← citeshttps://doi.org/10.1111/joie.12079openalex-snapshot
Competitive Pressure and Innovation at the Firm Level
inferred← citeshttps://doi.org/10.1186/s12916-016-0564-zopenalex-snapshot
Quantifying the economic impact of government and charity funding of medical research on private research and development funding in the United Kingdom
inferred← citeshttps://doi.org/10.1561/1700000050openalex-snapshot
Structural Models of the Prescription Drug Market
inferred← citeshttps://doi.org/10.17016/ifdp.2017.1206openalex-snapshot
Comparative Advantage in Innovation and Production
inferred← citeshttps://doi.org/10.3386/w18235openalex-snapshot
Pharmaceutical Innovation and Longevity Growth in 30 Developing and High-income Countries, 2000-2009
inferred← citeshttps://doi.org/10.3386/w20212openalex-snapshot
Pharmaceutical Profits and the Social Value of Innovation
inferred← citeshttps://doi.org/10.3386/w33855openalex-snapshot
The Structural Transformation of Innovation
inferred← citeshttps://doi.org/10.48550/arxiv.2111.15389openalex-snapshot
Product recalls, market size and innovation in the pharmaceutical industry
inferred← citeshttps://doi.org/10.70675/7e9e114cz48b9z4bfczb65az01f6f625c7f4openalex-snapshot
Innovation produit et performance des entreprises dans l'industrie laitière française
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.